Joshua Hutton

TL;DR: Reference data on the UK cancer research funding system are used as a case study to demonstrate the utility of funding data for strategic intelligence applications (e.g., mapping of funding landscape and co‐funding activity, comparison of funders' research portfolios).

TL;DR: The argument that the process of health system strengthening provides the most promising mechanism of benefiting both goals is supported, both conceptually and empirically.

TL;DR: In this paper, the authors explored the extent to which funders of cancer research are interdependent, nationally and internationally, and found that there are substantial benefits, both financial and qualitative, from the existence of a variety of funders and that reductions in the level of government financial support for medical research are likely to have broader negative effects.

TL;DR: The authors thank the advisory group for their time and thoughtful responses to the authors' questions, and all the interviewees, workshop attendees, survey respondents, and University of Sussex staff who contributed to the piloting of the surveys.

TL;DR: A novel dataset of manually extracted and coded data on the funding acknowledgements of 7,510 publications representing UK cancer research in the year 2011 is used to compare these 'reference data' with funding data provided by Web of Science (WoS) and MEDLINE/PubMed.